Clinical Study
Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
Table 3
Reasons for discontinuation of previous biologic therapy.
| First biologic drug used | | Primary failure | 5 | Secondary failure | 2 | Toxicity | 3 | Second biologic drug used | | Primary failure | 3 | Secondary failure | 4 | Toxicity | 0 | Third biologic drug used | | Primary failure | 2 | Secondary failure | 1 | Toxicity | 0 | Fourth biologic drug used | | Primary failure | 1 | Secondary failure | 0 | Toxicity | 0 |
|
|